[Cobalt teletherapy of the carcinoma of the urinary bladder (author's transl)].
A three-year survival rate of 40% of a group of 287 patients was achieved by a standardized Co-60 teletherapy. This survival rate and the radiogenic late effects observed over a ten-year period are compared with results communicated in literature. Important prognostic factors were the findings of a pretherapeutic urogram, the tumor localization, histologic findings, the stade and the surgical proceeding. In this connexion, the W.H.O. classification containing the stades of penetration and the degrees of malignity proved to be valuable. Taking into consideration the own results and those found in literature, the authors propose a therapy depending on the stade and based on modern diagnostic methods and a reliable histologic classification.
D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011379:Prognosis; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
D003037:Cobalt Radioisotopes
Telekobaltbestrahlung des Harnblasenkarzinoms.